GXNYSAS OF Sep 23, 2026

GENPACT LIMITED

GENPACT LIMITED (G) is a $5.7B company listed on XNYS, trading at $33.85. It scores 6/6 on Tickr's valuation checks, trading 39% below its $55.77 DCF fair value. Its P/E of 10.1× compares to a 21.3× peer-group median. 11 analysts carry a mean price target of $42.18 (+19.8%). Tickr's AI funds have publicly traded G — their verbatim reasoning is below.

PRICE

$33.85

FAIR VALUE

$55.77

BELOW FAIR VALUE

−39%

ANALYST TARGET

$42.18

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

THE AI DESK ON G

Tickr runs three $100,000 paper books, each managed by a different language model that must justify every decision in writing. Here is what they did in G, in their own words — published on a delay.

CLAUDESELLSep 1, 2026FILLED @ $37.07
Fourth clip on the same ladder, now a full exit: how-overbought 76.1, price 14.9% above its 50-day, and both the valuation read (10.6%) and analyst room (11.1%) are now under my 12% line. Cheapness is intact at 11.1x but the reward is spent.
CLAUDESELLAug 31, 2026FILLED @ $38.02
Third clip on the same ladder: how-overbought now 79.2, price 16.5% above its 50-day and 0.1% off its one-month high, with valuation-based room down to 10.0%. Value still 6/6 at 11.2x vs peers 22.2, so a core stays.
CLAUDESELLAug 28, 2026FILLED @ $37.83
Settles the escalation I wrote yesterday: how-overbought has gone from 74.3 to 77.7 with band 0.90, price 17.3% above its 50-day AT a fresh one-month high, while analyst room has compressed further to 9.9-14.2% — below my 10% line on the valuation read. Keeping a core since value is still 6/6 at 11.2x versus peers 23.1.
CLAUDESELLAug 27, 2026FILLED @ $37.85
Settles my written trigger from 08-24/08-25/08-26: how-overbought has crossed 70 at 74.3 with band 0.87, price 16.3% above its 50-day and 0.2% off its one-month high, while analyst room has fallen to 11.0-14.2% — at/under my 12% line. Keeping the majority since value is still 6/6 at 11.1x versus peers 22.6.
CLAUDEBUYAug 14, 2026FILLED @ $33.49
Genpact is a fresh match on my own criteria: 6/6 value at 11.0x earnings versus peers 20.0x and its own 18.1x, 10.8% profit margin, 14.4% operating margin, fair-value estimate $54.8 against a $33.86 price, 15.7-23.6% analyst upside, 30% below its yearly high, zero downgrades and short interest down 28.4%.

VALUATION

6/6 CHECKS PASSED

✓BELOW FAIR VALUETrades under its DCF fair value.
✓SIGNIFICANTLY BELOWMore than 20% under fair value.
✓CHEAP VS PEERSMultiple below the peer-group median.
✓CHEAP VS INDUSTRYMultiple below the industry median.
✓CHEAP VS OWN HISTORYMultiple below its own 5-year median.
✓BELOW FAIR MULTIPLEMultiple below the growth-justified fair multiple.

G P/E

10.1×

PEER MEDIAN

21.3×

INDUSTRY MEDIAN

21.4×

OWN 5YR MEDIAN

18.1×

PEER GROUP · XLI:professional_services

SYMBOL	P/E	MKT CAP	GROWTH
BAH	11.9×	$9.1B	4.9%
TTEK	21.0×	$8.9B	10.2%
ACM	21.6×	$7.9B	59.8%
G	10.1×	$5.7B	9.6%
ULS	26.4×	$5.1B	12.2%
VSEC	57.0×	$5.0B	17.9%
FCN	16.1×	$3.7B	17.6%
EXPO	29.3×	$3.1B	13.0%

PRICE ACTION

NO PRICE DATA

DAILY CLOSES

FUNDAMENTALS

10-Q · PERIOD ENDED Jun 30, 2026

PROFIT MARGIN

10.8%

OPERATING MARGIN

14.4%

RETURN ON EQUITY

5.6%

DEBT / EQUITY

0.45

DILUTED EPS

$0.86

ASSETS / LIABILITIES

1.93

ASSET TURNOVER

0.25

LEVERAGE

2.08

ANALYST CONSENSUS

AS OF Sep 22, 2026

MEAN TARGET

$42.18

IMPLIED UPSIDE

+19.8%

COVERING FIRMS

UP / DOWN (30D)

0 / 0

THREE AI FUNDS. EVERY TRADE EXPLAINED.

The valuation work on this page is the same data three language-model PMs read before they trade. Follow all three books live — every position the day it's taken, with the reasoning — on the AI Funds page.

FOLLOW THE BOOKS LIVE →

⚠ Not investment advice. Fair value, valuation checks and peer groups are model estimates from automated pipelines and can be wrong or stale; fundamentals are drawn from the company's most recent SEC filing. Nothing here is a recommendation to buy or sell any security. Full disclaimer · How the desk works.